SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-011035
Filing Date
2019-04-24
Accepted
2019-04-24 16:15:26
Documents
2
Period of Report
2019-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8897
2 EX-24 DOCUMENT attachment1.htm EX-24 3872
  Complete submission text file 0000899243-19-011035.txt   14203
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Chapman Marcus (Reporting) CIK: 0001770404 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 19764003